Skip to content
OpenCapital
Get started

USANA Health Sciences USNA PP&E Sale Proceeds

PP&E Sale Proceeds at other companies

Lifevantage Corporation logo
Lifevantage CorporationLFVN
$0—

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$394.19M-30.9%
P/E19.7×+8.5×
P/S0.4×-0.2×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's pp&e sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's PP&E sale proceeds?
USANA Health Sciences (USNA) reported PP&E sale proceeds of $48K in Q1 2026.
What is the long-term trend for USANA Health Sciences's PP&E sale proceeds?
Over 2 years (2022 to 2025), USANA Health Sciences's PP&E sale proceeds has grown at a 2261.9% compound annual growth rate (CAGR), from $7K to $3.91M.
What does PP&E sale proceeds mean?
Cash received from selling property, plant, and equipment no longer needed for operations.